APASL STC 2022 on NAFLD/NASH: Non-Infection Epidemic in XXI Century

Date: OCTOBER 6-8, 2022

City: Yerevan

Venue: Elite Plaza Business Center in Yerevan

President: Hasmik Ghazinyan, MD PHD

Welcome Message,

I have the great pleasure of inviting you to join us at APASL STC on NAFLD/NASH to be held from 6 to 8 October 2022, in Yerevan, Armenia.

Non-alcoholic fatty liver disease (NAFLD) is a very common disorder and refers to a group of conditions where there is accumulation of excess fat in the liver of people who drink little or no alcohol. THE GLOBAL  PREVALENCE  OF NAFLD: About one-fourth of the world’s population has NAFLD, the most common form of NAFLD is a non-serious condition called fatty liver. In the fatty liver, fat accumulates in the liver cells. Although having fat in the liver is not normal, by itself it probably does not damage the liver. A small group of people with NAFLD may have a more serious condition named non-alcoholic steatohepatitis (NASH). In NASH, fat accumulation is associated with liver cell inflammation and different degrees of scarring. NASH is a potentially serious condition that may lead to severe liver scarring and cirrhosis and HCC.

This three-day meeting will focus on all aspects of the management of NAFLD/NASH and will include important topics of epidemiology, Causes

Symptoms, Risk Factors, Screening/Diagnosis as well as optimal current treatment approaches in patients including. Our aim is to invite all experts in the field to present the latest research data and share their experiences as well as to create new plan for the future. STC will be based on active discussion and interactions in order to get necessary results and new challenges in NAFLD/NASH (MAFLD?). We are expecting 500 delegates from the whole world including CIS countries to attend this important conference.

I hope you will enjoy this conference as well as your stay in Armenia, the country with old history, culture and amazing hospitality and traditions.

SECRETARY APASL NASH 2022 GAGIK HAKOBYAN	PRESIDENT APASL NASH 2022 HASMIK GHAZINYAN MD, PHD Head of Hepatological clinic of NCID (National Centre for Infectious Diseases) President of Armenian Hepatological Association for the study of the liver

NATIONAL ADVISORY COMMITTEE
ALEXANDER BAZARCHYAN Director of the National Institute of Health of the Ministry of Health of the Republic of Armenia	NAREK VANESYAN President of the National Medical Palace of the Republic of Armenia	VARDAN AVAGYAN Director of National Centre for Infectious Diseases (NCID)

INVITED GUEST/SPEAKERS FROM ARMENIA
Ghazinyan Hasmik	Navoyan Lusine	Grigoryan Mari
Aghajanova Elena	Safaryan Ruzanna	Sargsyan Sona
Khemichyan Saro	Sargsyants  Narina	Khondkaryan Ruzanna
Mkhoyan Anna	Grigoryan Sofya	Gemilyan Manik
Avagyan Lusine	Gabrielyan Asya	Navoyan Iskuhi
Baghdasaryan Edmond	Hazoyan Anna	Karabakhtsyan Anush
Keryan Ashkhen

INTERNATIONAL INVITED GUESTS
Dr. SHIV KUMAR SARIN	Professor, Hepatology, & Director, ILBS	INDIA
Dr. MASAO OMATA	The University of  Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan	JAPAN
Dr. HAN-CHIEH LIN	Fellow, American Association for the Study of Liver Diseases (FAASLD) Fellow, American College of Gastroenterology (FACG) Member, European Association for the Study of the Liver (EASL) Executive Council Member (2017/1-2020/12), Asian Pacific Association for the Study of the Liver (APASL) President (2023), Asian Pacific Association for the Study of the Liver (APASL) President (2020/1-2022/12), Taiwan Association for the Study of the Liver (TASL) Executive Council Member (2013/1-present), Taiwan Association for the Study of the Liver (TASL) Councilor (2017/5-present), The Taiwan Liver Cancer Association	TAIWAN
ZOBAIR M. YOUNOSSI	MD, MPH Professor and Chairman of the Department of Medicine, Inova Fairfax Hospital. The Global NASH Consil	USA
ROBERT G. GISH	Professor of Medicine & Attending Physician Loma Linda University Clinical Professor of Medicine (Adjunct) University of Nevada (Las Vegas) Clinical Professor of Medicine (Adjunct) University of Nevada (Reno) Clinical Professor University of California (San Diego) Skaggs School of Pharmacy & Pharmaceutical Sciences Medical Director, Hepatitis B Foundation Doylestown, PAMedical Director, Asia Pacific Health Foundation San Diego, CA	USA
GEORGE LAU	Chairman and Senior Consultant in Gastroenterology and Hepatology, Humanity and Health Medical Group, HKSAR, China Chair Professor and Co-Director, Liver Disease and Transplant, The 5th Medical Centre of Chinese PLA General Hospital (Beijing 302 Hospital) – Hong Kong Humanity & Health Medical Group, Beijing, China Director, Community and Public Hospitals COVID-19 Vaccination Centers, Hong Kong SAR, China	HONG KONG
MOHAMMED ESLAM	Associate professor of hepatology at Store liver center, Sydney University	SYDNEY
Dr. GAMAL SHIHA	Professor of Internal Medicine, and the Head of the Gastrointestinal & Liver Unit at Mansoura University	EGYPT
PASCAL PINEAU	Research director Professional Address – Unité «Organisation Nucléaire et Oncogenèse» INSERM U993, Institut Pasteur, 28, rue du Docteur Roux F-75724 Paris cedex 15,	FRENCH
YASSER MAHROUS FOUAD	M.D, Professor of Gastroenterology and Hepatology Minia Head of Departement of Gastroenterology, Minia International Hospital	EGYPT
Dr. VINCENT WONG	Mok Hing Yiu Professor of Medicine Department of Medicine and Therapeutics Faculty of Medicine The Chinese University of Hong Kong Tel: (852) 3505-1299 | Fax: (852) 2637-3852 | E-mail: wongv@cuhk.edu.hk	HONG KONG
Dr. BADAL KUMAR	Professor liver transplant surgery	INDIA
Dr. COSMAS RINALDI A LESMANA	Sp.PD, KGEH PhD, F.A.C.P, F.A.C.G, FINASIM Assistant Professor, Senior Lecturer & Consultant Gastroenterology & Hepatology Education sub-committee Asian EUS Group (AEG)​ Member American Society of Gastrointestinal Endoscopy (ASGE) Past Asian Pacific Association for The Study of The Liver (APASL) Executive Council Member Department of Internal Medicine, Hepatobiliary Division, Dr. Cipto Mangunkusumo National General Hospital, Medical Faculty Universitas Indonesia, Jakarta Digestive Disease & GI Oncology Center, Medistra Hospital, Jakarta Gastrointestinal Cancer Center, MRCCC Siloam Semanggi Hospital, Jakarta​ INDONESIA	INDONESIA
Dr. JACOB GEORGE	MBBS, PhD Current Academic or Administrative Positions: Robert W. Storr Professor of Hepatic Medicine at the Storr Liver Centre, Westmead Institute for Medical Research, University of Sydney and Head of the Department of Gastroenterology and Hepatology at Westmead Hospital and Director of Gastroenterology and Hepatology Services for the Western Sydney Local Health District	AUSTRALIA
ADAMS LEON	Consultant Hepatologist Department of Hepatology and Liver Transplant Unit, Sir Charles Gairdner Hospital Medical School, Faculty of Medical & Health Sciences, UWA​ ​ •​ ​ M503,​ Perth WA 6009 Australia	AUSTRALIA
Dr. DIANA A PAYAWAL	MD, DTMH, FPCP, FPSG, FPSDE, LIM-SEA (Harvard) Professor II Chair, Department of Internal Medicine Fatima University Medical Center Chair Committee of Hepatology Cardinal Santos Medical Center Vice President, Philippine College of Physicians Past President, Asian Pacific Study of the Liver Past President,​ Philippine Society of Gastroenterology Past President, Hepatology Society of the Philippines	PHILIPPINES
HIDEKI FUJII		JAPAN
Prof. Dr NECATI ÖRMECI	İstanbul Health and Technology University. normeci@yahoo.com	TURKEY
Dr. AJAY DUSEJA	MBBS, MD, DM Current Academic or Administrative Positions: Professor in the department of Hepatology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.	INDIA
Dr. MANOJ KUMAR SHARMA	Professor and Head Department of Hepatology and Liver Transplantation Institute of Liver & Biliary Sciences, New Delhi, India NAFLD/MAFLD, HCC, Quality of life in cirrhosis, Portal hypertension, hepatitis B, AUD, Sleep disorders in cirrhosis Secretary General cum Treasurer, APASL Associate Dean APASL School of Hepatology Chairman Guidelines committee, APASL Assistant Director, World Gastroenterology Organization (WGO) New Delhi International Training Center at Institute of Liver and Biliary Sciences, New Delhi Board of Directors, Asia Pacific  Digestive Week (APDW) Federation Associate Editor, Hepatology International PUBLICATIONS ORIGINAL ARTICLES : 145 PUBLICATIONS: REVIEWS: 58 H- INDEX=45	INDIA
Dr. JEFFREY V. LAZARUS	ISGlobal and University of Barcelona jeffrey.lazarus@isglobal.org	SPAIN
Dr. NERSESOV ALEXANDER	President, Kazakh Association for the Study of the Liver Head, Department of Gastroenterology, Hepatology and Endoscopy National Research Institute of Cardiology and Internal Diseases	KAZAKHSTAN
PAVEL BOGOMOLOV	Chief hepatologist of the Moscow region, head of the hepatological department, deputy chief physician of the MONIKI named after M.F. Vladimirsky for Clinical and Diagnostic Work, Head of the Moscow Regional Hepatological Center, Candidate of Medical Sciences	MOSCOW
ALEXEY BUYEVEROV	MD, Professor of the Department of Medical and Social Expertise, Emergency and Polyclinic Therapy at Institute of Vocational Education, First Moscow State Medical University (Sechenov University); lead research scientist at MONIKI named after M.F. Vladimirsky; member of the dissertation council at Moscow Clinical Scientific Center named after A.S. Loginov; President of the Evidence-Based Medicine Foundation, Director of the Moscow Medical Academy, a private institution of additional professional education. Author of more than 250 scientific papers, including 20 manuals, monographs and training manuals, 3 patents for inventions. Conducts active scientific and teaching work, participates in scientific and practical conferences as a moderator and speaker, including international congresses and symposiums. An active member of domestic and foreign scientific societies of gastroenterologists, hepatologists and infectious disease specialists.	MOSCOW
RAKHMATOVA VENERA	Doctor of Medical Sciences, Head of the Hepatological Center of Astana, Chief Gastroenterologist (Hepatologist) of Astana.	KAZAKHSTAN

TOPICS

• Multidisciplinary Approaches and Lifestyles Interventions for the Management of NAFLD

• MAFLD definition is more practical for identifying patients with fatty liver disease

• Alcoholic and non-alcoholic fatty liver disease: a comparative analysis

• The role of gut microbiota in the pathogenesis of NAFLD and NASH

• Current Available Pharmacological therapeutic  Options for NAFLD

• Patient Guidelines Focusing on Non-alcoholic Fatty Liver Disease

• Drug Development Overview and Clinical Pharmacology

• NAFLD Pathophysiology: Targets for Novel Treatments

• Global Epidemiology and Outcomes of the NAFLD

• Economic and Clinical Burden of NAFLD

• Tools  to Assess Severity in NAFLD

• MRI  and Ultrasound and NASH

• NAFLD and Immune Response

• Non-Invasive Tests for NAFLD

• Bariatric Surgery for NAFLD

• NAFLD and Malignancy

• Newly Available Agents

• Biomarkers in NAFLD

• Life style and NAFLD

• Dietary Managment

• NAFLD in Children

• ACLF and NAFLD

SPONSORS